Illinois § 5-58 Illinois Medicaid Preferred Drug List; nonopioid drugs

Illinois Statutes

§ 5-58 — Illinois Medicaid Preferred Drug List; nonopioid drugs

Illinois § 5-58

JurisdictionIllinois

TopicHUMAN NEEDS

Ch. 305PUBLIC AID

Act 305 ILCS 5/Illinois Public Aid Code.

Art.Article V - Medical Assistance

This text of Illinois § 5-58 (Illinois Medicaid Preferred Drug List; nonopioid drugs) is published on Counsel Stack Legal Research, covering Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

305 Ill. Comp. Stat. 5-58 (2026).

Text

In establishing and maintaining the Illinois Medicaid Preferred Drug List as described in Section 5-30.14, the Department shall ensure that nonopioid drugs on the Department's preferred drug list, and approved by the U.S. Food and Drug Administration, for the treatment or management of pain shall not be disadvantaged or discouraged with respect to coverage relative to any opioid or narcotic drug for the treatment or management of acute pain as long as the Department retains its authority to manage the Preferred Drug List process pursuant to State or federal law, rules, regulations, and policies and the Department's authority over the Preferred Drug List process is not undermined or compromised.

Free access — add to your briefcase to read the full text and ask questions with AI

In establishing and maintaining the Illinois Medicaid Preferred Drug List as described in Section 5-30.14, the Department shall ensure that nonopioid drugs on the Department's preferred drug list, and approved by the U.S. Food and Drug Administration, for the treatment or management of pain shall not be disadvantaged or discouraged with respect to coverage relative to any opioid or narcotic drug for the treatment or management of acute pain as long as the Department retains its authority to manage the Preferred Drug List process pursuant to State or federal law, rules, regulations, and policies and the Department's authority over the Preferred Drug List process is not undermined or compromised.